Elisigen, Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| NG101 AAV Gene Therapy in Subjects With Wet Age-Related Macular Degeneration (NCT05984927) | Elisigen, Inc. | 2023-09-08 |
Track Elisigen, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.